Puma Biotechnology

Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Puma Biotechnology
Takeda
Aurora A/angiogenic kinase inhibitor
clinical trials
Alisertib
Flag link:
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology
Flag link:
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Motley Fool
Clovis Oncology
Immunomedics
Puma Biotechnology
cancer
Flag link:
Will Puma Biotechnology Break Out of Its Rut in 2020?
Will Puma Biotechnology Break Out of Its Rut in 2020?
Motley Fool
Puma Biotechnology
Nerlynx
Xeloda
Flag link:
Puma Biotech’s Nerlynx remains a dud. Will a breast cancer expansion turn things around?
Puma Biotech’s Nerlynx remains a dud. Will a breast cancer expansion turn things around?
Fierce Pharma
Puma Biotechnology
Nerlynx
breast cancer
Flag link:
Puma Biotechnology Has a Simple Plan to Get Back to Growth
Puma Biotechnology Has a Simple Plan to Get Back to Growth
Motley Fool
Puma Biotechnology
Nerlynx
breast cancer
Flag link:
Here's Why Puma Biotechnology Fell 24.1% in July
Here's Why Puma Biotechnology Fell 24.1% in July
Motley Fool
Puma Biotechnology
earnings
Flag link:
Breast cancer survival data buoys Macrogenics and Puma
Breast cancer survival data buoys Macrogenics and Puma
Biopharma Dive
Macrogenics
margetuximab
Puma Biotechnology
Nerlynx
breast cancer
ASCO 2019
Flag link:
Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter. What gives?
Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter. What gives?
Fierce Pharma
Puma Biotechnology
Nerlynx
drug launches
Flag link:
Here's Why Puma Biotechnology Tumbled on Monday
Here's Why Puma Biotechnology Tumbled on Monday
Motley Fool
Puma Biotechnology
Nerlynx
Flag link:
3 Takeaways from Puma Biotechnology's 2018 Earnings
3 Takeaways from Puma Biotechnology's 2018 Earnings
Motley Fool
Puma Biotechnology
earnings
Flag link:
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
Motley Fool
TG Therapeutics
Madrigal Pharmaceuticals
Puma Biotechnology
Flag link:
Here's Why Puma Biotechnology Tanked 37.3% in November
Here's Why Puma Biotechnology Tanked 37.3% in November
Motley Fool
Puma Biotechnology
Nerlynx
breast cancer
Flag link:
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Flag link:
CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar
CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar
Endpoints
Puma Biotechnology
Europe
CHMP
EMA
neratinib
Nerlynx
breast cancer
Flag link:
Ex-Puma exec sentenced to prison stretch on insider-trading conviction — ‘greed’ made me do it
Ex-Puma exec sentenced to prison stretch on insider-trading conviction — ‘greed’ made me do it
Endpoints
insider trading
Puma Biotechnology
Flag link:
Puma shares plummet as results from key trial delayed
Puma shares plummet as results from key trial delayed
Biopharma Dive
Puma Biotechnology
earnings
Nerlynx
clinical trials
Flag link:
Why Puma Biotechnology Shares Jumped 15% Friday
Why Puma Biotechnology Shares Jumped 15% Friday
Motley Fool
Puma Biotechnology
earnings
Nerlynx
breast cancer
Flag link:
Watch These February Biotech Catalysts
Watch These February Biotech Catalysts
Seeking Alpha
biotech
Dynavax
HEPLISAV-B
vaccines
Novavax
NanoFlu
Nerlynx
Puma Biotechnology
breast cancer
Flag link:
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Endpoints
Puma Biotechnology
CHMP
neratinib
cancer
Europe
Flag link:

Pages